Peter A. McCullough, MD, MPH™ – Telegram
Peter A. McCullough, MD, MPH
27K subscribers
747 photos
611 videos
14 files
4.99K links
Physician-scientist, author, commentator, Chief Scientific Officer, The Wellness Company, President, McCullough Foundation, www.petermcculloughmd.com
Download Telegram
Novavax is a new vaccine option made in the USA. Novavax is a more traditional protein-based vaccine. It does not contain mRNA or viral vectors. Novavax works by attaching COVID spike proteins to a nanoparticle. Then an immune activating component, Saponin (soap-tree bark), is added to boost the immune response to the COVID spike proteins. Novavax is highly effective against the original coronavirus(96%) and the alpha variant (93%), but less so against the beta variant (55%). Novavax could be a good option for people who are concerned about the other vaccines currently available. Unfortunately NIH BARDA is not accelerating/funding expeditious market entry. https://www.youtube.com/watch?v=tlB-5E-wpU0
Humetrix Analysis reveals as Delta shades in, among CMS over age 65, vaccinated account for 60% Americans hospitalized with COVID-19
Pfizer vaccine has completely failed in Israel. See this Israel news casts and read the subnoscripts. There is absolutely zero impact of the Pfizer vaccine on new cases or hospitalizations. https://www.bitchute.com/video/aawp4Jqzawh2/
High Recorded Mortality in Countries Categorized as “Covid-19 Vaccine Champions”. The Vaccinated Suffer from Increased Risk of Mortality compared to the Non-vaccinated
Data on Mortality in the Most Vaccinated Countries. Increased Hospitalizations of the Vaccinated
By Gérard Delépine
Global Research, September 30, 2021 https://www.globalresearch.ca/high-recorded-mortality-in-countries-categorized-as-covid-19-vaccine-champions-increased-hospitalization/5757173
Colleagues

Please see this report from one of the earliest COVID-19 treatment groups in France let by C19 legend Dr. Didier Raoult confirming the effectiveness of HCQ in combination with AZM very early in the course of COVID-19.

https://rcm.imrpress.com/EN/10.31083/j.rcm2203116

The accompanying editorial by Drs. McCullough, Stricker, and Risch is here:

https://rcm.imrpress.com/EN/10.31083/j.rcm2203063

Million M, Lagier JC, Tissot-Dupont H, Ravaux I, Dhiver C, Tomei C, Cassir N, Delorme L, Cortaredona S, Amrane S, Aubry C, Bendamardji K, Berenger C, Doudier B, Edouard S, Hocquart M, Mailhe M, Porcheto C, Seng P, Triquet C, Gentile S, Jouve E, Giraud-Gatineau A, Chaudet H, Camoin-Jau L, Colson P, Gautret P, Fournier PE, Maille B, Deharo JC, Habert P, Gaubert JY, Jacquier A, Honore S, Guillon-Lorvellec K, Obadia Y, Parola P, Brouqui P, Raoult D. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients. Rev Cardiovasc Med. 2021 Sep 24;22(3):1063-1072. doi: 10.31083/j.rcm2203116. PMID: 34565108.

McCullough PA, Stricker RB, Risch HA. Role of hydroxychloroquine in multidrug treatment of COVID-19. Rev Cardiovasc Med. 2021 Sep 24;22(3):545-546. doi: 10.31083/j.rcm2203063. PMID: 34565055.
Role of hydroxychloroquine in multidrug treatment of COVID-19
Peter A. McCullough1, *, Raphael B. Stricker2, Harvey A. Risch3
1Truth for Health Foundation, Tucson, AZ, USA
2Union Square Medical Associates, San Francisco, CA, USA
3Yale School of Public Health, New Haven, CT 06510, USA
https://www.americaoutloud.com/boosters-could-mean-regular-injections-are-part-of-your-life-forever/
On February 17, 2021, presentations were made by multiple scientists who concluded that: 1) deaths after vaccination are unacceptable, 2) the risk of death occurring within a few days of injection is greater than the risks of acquiring COVID-19 and succumbing to the disease, 3) the risk of hospitalization for myocarditis (heart damage) after vaccination is greater than that of contracting COVID-19 and later becoming hospitalized for respiratory failure.

Inarguably, the three outcomes to avoid with either choice are 1) death, 2) hospitalization, and 3) permanent disability.

What we are witnessing is that many Americans have made their choice and would rather risk a COVID-19 hospitalization than immediate death or injury with vaccination. Following the theme of pharmacovigilance, we have a special guest on this show: Dr. Jessica Rose has a BSc in Applied Mathematics and completed her MSc in Immunology at the Memorial University of Newfoundland in Canada. She completed her Ph.D. in Computational Biology at Bar Ilan University and then did her first Post Doctorate at the Hebrew University of Jerusalem in Molecular Biology. She made a compelling presentation to the US FDA at the September 17, 2021 hearings that historians will record as seminal.

So let’s get real, let’s get loud, on America Out Loud Talk Radio, this is The McCullough Report!